Endovascular Engineering, Inc.
Explore this company’s associated devices, FDA decisions and regulatory history.

Endovascular Engineering, Inc.
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Endovascular Engineering, Inc.. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Oct 11, 2026 to Oct 11, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code SHJ appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 3925 Bohannon Dr., Suite 300, Menlo Park, CA, 94025, US. Recorded on K253717, decision dated Oct 11, 2026.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Devices & associated records
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Helo ReturnK253717 | Endovascular Engineering, Inc. | 510(k) clearance | Oct 11, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 20, 2026.
